8th May 2014 13:31
LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said a group of Directors and non-executives bought shares in the central laboratory and molecular diagnostics business.
Details are as follows.
Director | No. of ordinary shares purchased | Purchase price | Total shareholding before purchase | Total shareholding following purchase | Percentage of issued share capital |
Julian Baines, Chief Executive Officer | 100,000 | 25.07p | 1,621,955 | 1,721,955 | 0.41% |
David Evans, Executive Chairman | 100,000 | 25.07p | 1,605,753 | 1,705,753 | 0.40% |
Paul Foulger, Chief Financial Officer | 50,000 | 25.07p | 3,438,589 | 3,488,589 | 0.83% |
Richard Evans, Chief Operating Officer | 25,000 | 25.07p | 153,842 | 178,842 | 0.04% |
Adam Reynolds, Non-Executive Director | 25,000 | 25.07p | 3,204,724 | 3,229,724 | 0.77% |
Kevin Wilson, Non-Executive Director | 50,000 | 25.07p | 617,846 | 667,846 | 0.16% |
Shares were up 1.0% 25.75 pence Thursday.
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Ekf Diagnostics